Join Us at ASM Microbe 2023

Are you attending ASM Microbe 2023? Join us at booth 1301 to learn more about how BD Integrated Diagnostic Solutions can help to drive laboratory efficiencies and support clinical decisions through integrated automation and testing innovation to meet your evolving needs.

System and product demonstrations will include:

• BD Kiestra™ InoqulA
• BD COR™ System
• BD MAX™ System
• BD Synapsys™ Informatics
• BD BSI Solution, featuring Magnolia’s Steripath^® and Accelerate’s Pheno^® system
• BD Vacutainer^® Specimen Management

Innovations in Molecular Testing for both Sexual Health and GI Pathogens

June 16th at 6:00pm in Ballroom A, Hilton Americas-Houston Hotel

Barbara Van Der Pol, PhD, MPH Professor of Medicine & Public Health President, International Society for STD Research	Margie Morgan, PhD, MT(ASCP), D(ABMM) Professor of Pathology and Laboratory Medicine Scientific Director, Clinical Microbiology Cedars-Sinai Medical Center	Heba Mostafa, MD, PhD, D(ABMM) Associate Professor, Department of Pathology, Johns Hopkins University School of Medicine Director, Molecular Virology Laboratory, The Johns-Hopkins Hospital

This symposium will have two sessions. The first, Moving toward more comprehensive sexual health care for women and men, featuring Dr. Barbara Van Der Pol, PhD, MPH, will discuss testing for sexually transmitted infections (STI), co-infection rates between STIs and vaginitis, the importance of offering a broad menu of testing for symptomatic women, and advances in STI testing.

The second, Implementing molecular diagnostic testing for gastrointestinal (GI) pathogens, featuring Margie Morgan, PhD, MT(ASCP), D(ABMM) and Heba Mostafa, MD, PhD, D(ABMM), will discuss the importance of providing molecular testing options for clinically relevant enteric pathogens in line with the 2017 IDSA Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea, and how transitioning from conventional culture to molecular testing can significantly improve sensitivity, specificity, and time to results, as well as factors to consider when deciding between comprehensive panels or a more focused, targeted approach.

Revolutionizing Blood Culture Quality: Exploring some of the Latest Technologies and the Vital role of Blood Culture Quality for Improving Patient Outcomes

June 17th at 6:00pm in Ballroom B, Hilton Americas-Houston Hotel

R. Phillip Dellinger, MD, FCCM, FCCP Professor of Medicine Emeritus and Distinguished Scholar at Cooper Medical School of Rowan University (CMSRU)	Lisa L Steed, PhD Director of Diagnostics Microbiology, MUSC	Jenny Meredith, PhD Clinical Microbiology Director, Prisma Health	Jordan Cardinal PharmD, BCPS is the Microbiology Medical Science Liaison for the U.S. Region in Integrated Diagnostic Solutions BD

This symposium explores the clinical implications of blood culture quality on sepsis patient care and hospital-onset bacteremia. Healthcare and laboratory professionals alongside industry and disease state experts will discuss the profound impact poor quality can have on patient morbidity, mortality, and healthcare costs. They also will share blood culture best practices, including the latest technologies, that have been clinically proven to improve overall blood culture quality. Lastly, the importance of optimized use of both techniques and technologies will be discussed to ensure that the invaluable diagnostic tool, blood cultures, are producing results with the highest sensitivity and specificity so that patients receive the best care possible.